RespireRx Pharmaceuticals, Inc. (RSPI)
Stock Price: $0.0346 USD
-0.0040 (-10.83%)
Updated Jan 15, 2021 9:30 AM EST - Market closed
| Market Cap | 187,238 |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -3.87M |
| Shares Out | 22.44M |
| EPS (ttm) | -0.04 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 15 |
| Last Price | $0.0346 |
| Previous Close | $0.0388 |
| Change ($) | -0.0040 |
| Change (%) | -10.83% |
| Day's Open | 0.0345 |
| Day's Range | 0.0302 - 0.0425 |
| Day's Volume | 2,384,324 |
| 52-Week Range | 0.02 - 1.499 |
News
There are no news available yet.
About RSPI
RespireRx Pharmaceuticals engages in the discovery and development of pharmaceuticals for the treatment of respiratory disorders. It has two drug platforms comprising ampakines, which are small molecule compounds to enhance the excitatory actions of the neurotransmitter glutamate at the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor complex; and cannabinoids, primarily dronabinol, a synthetic derivative for use in refractory chemotherapy-induced nausea and vomiting, as well as for anorexia in patients with AIDS. The co... [Read more...]
| Industry Biotechnology | Founded 1987 |
| Stock Exchange OTCMKTS | Ticker Symbol RSPI |